window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 3, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Funding

  • Biotech,Funding,Immunology,Oncology,Research & Development

    Laigo Bio raises €17m seed funding to advance oncology pipeline

    Laigo Bio has completed a €17 million seed financing round [...]

    March 23, 2026
  • Biotech,CDMOs & Manufacturing,Clinical Trials,Funding,Healthcare leadership,Oncology

    Mestag Therapeutics raises $40M and adds leadership ahead of cancer trial

    Mestag Therapeutics has raised $40 million and appointed two senior [...]

    March 23, 2026
  • Artificial Intelligence,Digital Health,Funding,Healthcare leadership,Pharmaceuticals and therapeutics

    Brainomix extends Series C to $25.4M to support US expansion

    Brainomix has extended its Series C financing by $6.5M (£4.8M), [...]

    February 24, 2026
  • Biotech,Clinical Development,Clinical Trials,Funding,Mergers & Acquisitions,Oncology,Pharmaceuticals and therapeutics

    Sensei acquires Faeth and secures $200M to advance PIKTOR in endometrial and breast cancer

    Sensei Biotherapeutics has acquired Faeth Therapeutics and announced a concurrent [...]

    February 19, 2026
  • Funding,Medical devices,Neurosciences,Startups and innovations

    Neupulse secures £3M to advance neurotherapeutic device for Tourette Syndrome

    Neupulse, a UK-based neurotherapeutics company, has raised £3 million in [...]

    February 16, 2026
  • Central Nervous System,Clinical Development,Clinical Trials,Funding

    Newron secures up to EUR 38 million to advance Phase 3 evenamide program in treatment-resistant schizophrenia

    Newron Pharmaceuticals has secured up to EUR 38 million in [...]

    February 16, 2026
  • Biologics & Biosimilars,Clinical Development,Drug approval,FDA,Funding,Pharmaceuticals and therapeutics,Rare Diseases,Regulatory Affairs

    Hansa Biopharma reports 135% Q4 revenue growth and BLA submission for imlifidase

    Hansa Biopharma has reported a 135% increase in fourth-quarter revenue [...]

    February 13, 2026
  • Funding,Oncology,Pharmaceuticals and therapeutics

    Kainova Therapeutics raises $32m CAD Series B to advance immuno-oncology and inflammation pipeline

    Kainova Therapeutics has secured $32m CAD in a Series B [...]

    February 10, 2026
  • Funding,Mergers & Acquisitions,Pharmaceuticals and therapeutics

    Juvisé Pharmaceuticals secures €550m refinancing led by Hayfin Capital Management

    Juvisé Pharmaceuticals has completed a €550m refinancing transaction led by [...]

    February 9, 2026
  • Digital Health,Funding,Global health,Mental health,Patient Centricity

    Wellcome awards £5.3m grant to Wysa for adolescent mental health study in India

    Wellcome has awarded £5.3m in funding to digital mental health [...]

    February 3, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Strategies to extend ketamine antidepressant effects identified in new study
    Categories: Central Nervous System, Mental health, Neurosciences, Research & Development
  • Bullfrog AI signs commercial agreement with top 5 global pharma company to identify novel target in major depressive disorder
    Categories: Artificial Intelligence, Digital Health, Mental health, Neurosciences, Research & Development
  • Bio-Sourcing and Tiny Cargo partner to develop oral monoclonal antibodies using milk exosomes
    Categories: Biotech, Drug Delivery & Formulation, Drug Development, Partnerships & Funding, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top